Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Human apotransferrin

EU orphan designation number: EU/3/18/2093   
Active ingredient: Human apotransferrin
Indication: Treatment of beta-thalassaemia intermedia and major
Sponsor: Sanquin Plasma Products B.V.
Plesmanlaan 125, 1066 CX Amsterdam, Nederland


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2018 Orphan designation EMA/OD/109/18 (2018)7803 of 19/11/2018